Researchers find clues for early screening and personalized management of Parkinson's disease

Scientists have uncovered new insights that could enable earlier prediction of Parkinson's disease progression and the development of tailored treatment plans. A study utilizing data from a national Parkinson's disease cohort identified potential early markers by analyzing thyroid signals. The research suggests that abnormalities in the autonomic nervous system, which can lead to symptoms like dizziness and fainting, might be detected earlier through these thyroid signal analyses. This could be crucial for managing non-motor symptoms that often accompany the disease. Furthermore, the study examined the impact of specific genetic types on disease progression. Researchers found that patients with a particular gene variant experienced faster deterioration in motor function and cognitive abilities, particularly in the frontal lobe, within three years of follow-up. These findings offer a basis for predicting patient prognosis and developing personalized monitoring and treatment strategies. The research underscores Parkinson's disease as a complex condition involving genetic factors, autonomic dysfunction, and cognitive changes, moving beyond its commonly known motor symptoms.

“

Parkinson's disease is not just a disease affecting movement, but a disease in which genetic factors, autonomic dysfunction, and cognitive changes are complexly involved.